DOXYCYCLINE HYCLATE capsule

Šalis: Jungtinės Valstijos

kalba: anglų

Šaltinis: NLM (National Library of Medicine)

Veiklioji medžiaga:

DOXYCYCLINE HYCLATE (UNII: 19XTS3T51U) (DOXYCYCLINE ANHYDROUS - UNII:334895S862)

Prieinama:

American Health Packaging

INN (Tarptautinis Pavadinimas):

DOXYCYCLINE HYCLATE

Sudėtis:

DOXYCYCLINE ANHYDROUS 100 mg

Vartojimo būdas:

ORAL

Recepto tipas:

PRESCRIPTION DRUG

Terapinės indikacijos:

To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections: - Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae. - Respiratory tract infections caused by Mycoplasma pneumoniae . - Lymphogranuloma venereum caused by Chlamydia trachomatis . - Psittacosis (ornithosis) caused by

Produkto santrauka:

Doxycycline hyclate capsules USP (equivalent to 100 mg doxycycline) are opaque blue capsules imprinted " DAN 5440 " supplied in unit dose packages of 30 (3 x 10) NDC 60687-118-21. Store below 30°C (86°F). FOR YOUR PROTECTION: Do not use if blister is torn or broken.

Autorizacija statusas:

Abbreviated New Drug Application

Prekės savybės

DOXYCYCLINE HYCLATE- DOXYCYCLINE HYCLATE CAPSULE
AMERICAN HEALTH PACKAGING
----------
DOXYCYCLINE HYCLATE CAPSULES USP
8411821/0518
RX ONLY
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of doxycycline
hyclate and other antibacterial drugs, doxycycline hyclate should be
used only to treat or prevent
infections that are proven or strongly suspected to be caused by
bacteria.
DESCRIPTION
Doxycycline is an antibacterial drug synthetically derived from
oxytetracycline, and is available as
doxycycline hyclate (doxycycline hydrochloride hemiethanolate
hemihydrate) for oral administration.
The structural formula of doxycycline hyclate is
with a molecular formula of (C
H
N
O
•HCl)
•C
H
O•H
O and a molecular weight of
1025.89. The chemical designation for doxycycline hyclate is
4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-
octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
monohydrochloride, compound with ethyl alcohol (2:1), monohydrate.
Doxycycline hyclate is a yellow
crystalline powder which is soluble in water.
Doxycycline has a high degree of lipoid solubility and a low affinity
for calcium binding. It is highly
stable in normal human serum. Doxycycline will not degrade into an
epianhydro form.
Each capsule, for oral administration, contains doxycycline hyclate,
equivalent to 50 mg or 100 mg of
doxycycline.
Each tablet, for oral administration, contains doxycycline hyclate,
equivalent to 100 mg of doxycycline.
Doxycycline hyclate capsules, USP 50 mg and 100 mg contain the
following inactive ingredients:
magnesium stearate and microcrystalline cellulose.
The capsule shells contain: FD&C Blue No. 1, gelatin and titanium
dioxide.
Doxycycline hyclate tablets, USP 100 mg contain the following inactive
ingredients: croscarmellose
sodium, FD&C Red No. 40, FD&C Yellow No. 6, hypromellose, magnesium
stearate, microcrystalline
cellulose, polyethylene glycol, polysorbate 80, sodium lauryl sulfate
and titanium dioxide.
CLINICAL PHARMACOLOGY
Tetracyclines are read